Vann Care Pharma Profile
Key Indicators
- Authorised Capital ₹ 9.50 Cr
as on 12-12-2024
- Paid Up Capital ₹ 6.50 Cr
as on 12-12-2024
- Company Age 3 Year, 1 Day
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 10.00 Cr
as on 12-12-2024
- Revenue %
(FY 2023)
- Net Worth 19798.93%
(FY 2023)
- Total Assets 527.63%
(FY 2023)
About Vann Care Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 9.50 Cr and a paid-up capital of Rs 6.50 Cr.
The company currently has active open charges totaling ₹10.00 Cr.
Jignesh Parikh, Pradipbhai Shah, Siddhant Parikh, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24290GJ2021PTC128230
- Company No.
128230
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Dec 2021
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Vann Care Pharma?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pradipbhai Shah  | Director | 24-Dec-2021 | Current |
| Jignesh Parikh | Director | 30-May-2023 | Current |
| Siddhant Parikh | Director | 30-May-2023 | Current |
| Hemant Gajjar | Director | 24-Dec-2021 | Current |
| Amey Gupta | Director | 30-May-2023 | Current |
Financial Performance of Vann Care Pharma.
Vann Care Pharma Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth Soared by an impressive increase of 19798.93%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Vann Care Pharma?
Unlock access to Vann Care Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Shree Vishwakarma Alu Projects Private LimitedActive 9 years 10 monthsHemant Gajjar is a mutual person
Airmax(Gujarat ) Pvt LtdActive 37 years 10 monthsJignesh Parikh and Siddhant Parikh are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 02 Jun 2023 | ₹10.00 Cr | Open |
How Many Employees Work at Vann Care Pharma?
Vann Care Pharma has a workforce of 0 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vann Care Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vann Care Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
